Your browser doesn't support javascript.
loading
Correction to: Pharmacokinetic Profile of Gilteritinib: A Novel FLT-3 Tyrosine Kinase Inhibitor.
James, Angela Joubert; Smith, Catherine C; Litzow, Mark; Perl, Alexander E; Altman, Jessica K; Shepard, Dale; Kadokura, Takeshi; Souda, Kinya; Patton, Melanie; Lu, Zheng; Liu, Chaofeng; Moy, Selina; Levis, Mark J; Bahceci, Erkut.
Afiliación
  • James AJ; Astellas Pharma US, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA. angela.james@astellas.com.
  • Smith CC; University of California San Francisco, San Francisco, CA, USA.
  • Litzow M; Mayo Clinic, Rochester, NY, USA.
  • Perl AE; University of Pennsylvania-Abramson Comprehensive Cancer Center, Philadelphia, PA, USA.
  • Altman JK; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA.
  • Shepard D; Cleveland Clinic, Cleveland, OH, USA.
  • Kadokura T; Astellas Pharma, Inc., Tokyo, Japan.
  • Souda K; Astellas Pharma, Inc., Tokyo, Japan.
  • Patton M; Astellas Pharma US, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA.
  • Lu Z; Astellas Pharma US, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA.
  • Liu C; Astellas Pharma US, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA.
  • Moy S; Astellas Pharma US, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA.
  • Levis MJ; John Hopkins University, Baltimore, MD, USA.
  • Bahceci E; Astellas Pharma US, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA.
Clin Pharmacokinet ; 60(9): 1251, 2021 Sep.
Article en En | MEDLINE | ID: mdl-34297319

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Clin Pharmacokinet Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Clin Pharmacokinet Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos